我国医药制造业经济产出状况及其影响因素分析
发布时间:2018-11-25 16:35
【摘要】:改革开放以来随着我国经济实力的不断增强,医药制造业得到迅猛发展,在国民经济体系中的地位逐步提高,医药制造业是关系人民生命健康的重要行业。随着人们对健康意识的提高,促使医药需求的增加,各国对医药领域的发展也越来越重视,现代医药产业进入快速发展的阶段,同时也由于其行业特殊性的存在,医药制造业也被称为“永远的朝阳产业”。 目的:通过对当前我国医药制造业经济产出状况分析了解当前医药制造业经济发展状况;构建影响因素指标体系并对指标体系进行量化分析,得出影响我国医药制造业经济产出水平的主要因素及各影响因素在不同时期的变化状况。在此基础上,提出提升我国医药制造业经济产出水平的对策建议,研究结果可为医药管理部门和企业进行管理决策提供数据支持和参考,同时也能为相关领域内的研究学者提供借鉴。 方法:本研究采用定性和定量相结合方法。采用绝对数、构成比、同比增长率等统计指标对当前我国医药制造业市场需求状况及经济产出状况进行描述性分析;并通过构建灰色GM(1,1)预测模型对未来我国医药制造业产能状况进行趋势预测;在文献分析基础上,从基本要素投入、医药科技因素、市场需求因素、对外开放程度因素、产业发展环境因素五大方面共11个因素,构建影响我国医药制造业产出的因素指标体系。并根据我国医药相关统计年鉴指标数据采用灰色关联法对影响因素进行量化处理,从而得出各个影响因素排序及变化状况。 结果:分析结果显示,我国医药制造业的发展还存在较多问题,例如医药制造企业规模小、集中程度低、地区医药制造业发展不平衡、地区特色不显著等,同时在对影响因素的分析中发现,我国医药制造业产出水平在一定时期内较大程度依赖于资金和劳动力的投入,近年来科技因素在工业发展过程中的作用有所提升,对外开放程度因素影响有所减弱,产业发展环境因素和市场需求因素在一定时期对医药制造业经济产出影响较为稳定。 结论:本研究以国家统计局、国家卫生和计划生育委员会、国家工业与信息化部、中国医药保健品进出口商会等国家医药管理与研究部门的权威数据为基础,分析数据真实可靠。在分析过程中以2006年和2010年我国28个省的影响因素数据为样本,结合数据样本量及数据的分布特征,选取灰色关联分析方法分析较为合适。在综合分析基础上进一步探讨改进建议与对策,从而提升我国医药制造业经济产出水平,促进医药制造业发展。
[Abstract]:Since the reform and opening to the outside world, the pharmaceutical manufacturing industry has been developing rapidly with the increasing economic strength of our country, and its position in the national economic system has been gradually improved. The pharmaceutical manufacturing industry is an important industry related to the life and health of the people. With the improvement of people's awareness of health and the increasing demand for medicine, more and more attention has been paid to the development of the field of medicine. The modern medicine industry has entered the stage of rapid development, and at the same time, because of the existence of its particularity, Pharmaceutical manufacturing is also known as the "sunrise industry forever." Objective: to analyze the economic output of pharmaceutical manufacturing industry in China. The index system of the influencing factors is constructed and the quantitative analysis of the index system is carried out. The main factors affecting the economic output level of the pharmaceutical manufacturing industry in China and the changes of the influencing factors in different periods are obtained. On this basis, the countermeasures and suggestions to improve the economic output level of pharmaceutical manufacturing industry in China are put forward. The research results can provide data support and reference for pharmaceutical management departments and enterprises to make management decisions. At the same time, it can also provide reference for researchers in related fields. Methods: qualitative and quantitative methods were used in this study. The market demand and economic output of pharmaceutical manufacturing industry in China are analyzed in terms of absolute number, composition ratio, annual growth rate and so on. And through the construction of grey GM (1 ~ 1) forecasting model, the trend of the future pharmaceutical manufacturing capacity in China is forecasted. On the basis of literature analysis, there are 11 factors in five aspects: input of basic elements, factors of pharmaceutical science and technology, factors of market demand, factors of degree of opening to the outside world, and environmental factors of industrial development. To construct the index system of factors influencing the output of pharmaceutical manufacturing industry in China. According to the index data of the medical statistics yearbook of our country, grey correlation method is used to quantify the influencing factors, and the order and change of the influencing factors are obtained. Results: the results show that there are still many problems in the development of pharmaceutical manufacturing industry in China, such as the small scale of pharmaceutical manufacturing enterprises, low concentration, unbalanced development of regional pharmaceutical manufacturing industry, unremarkable regional characteristics, etc. At the same time, through the analysis of the influencing factors, it is found that the output level of pharmaceutical manufacturing industry in China depends on the investment of capital and labor to a large extent in a certain period of time, and in recent years, the role of scientific and technological factors in the process of industrial development has been improved. The influence of the degree of opening to the outside world is weakened, and the factors of industrial development environment and market demand have a stable effect on the economic output of pharmaceutical manufacturing industry in a certain period of time. Conclusion: this study is based on the authoritative data of the National Bureau of Statistics, the National Health and Family Planning Commission, the Ministry of Industry and Information Technology, and the China Chamber of Commerce for the Import and Export of Health products. The analytical data are true and reliable. In the process of analysis, taking the data of the influencing factors of 28 provinces in 2006 and 2010 as samples, combining the sample size and the distribution characteristics of the data, it is more appropriate to select the grey relational analysis method to analyze. On the basis of comprehensive analysis, suggestions and countermeasures for improvement are further discussed in order to improve the economic output level of Chinese pharmaceutical manufacturing industry and promote the development of pharmaceutical manufacturing industry.
【学位授予单位】:北京中医药大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:F426.72
本文编号:2356761
[Abstract]:Since the reform and opening to the outside world, the pharmaceutical manufacturing industry has been developing rapidly with the increasing economic strength of our country, and its position in the national economic system has been gradually improved. The pharmaceutical manufacturing industry is an important industry related to the life and health of the people. With the improvement of people's awareness of health and the increasing demand for medicine, more and more attention has been paid to the development of the field of medicine. The modern medicine industry has entered the stage of rapid development, and at the same time, because of the existence of its particularity, Pharmaceutical manufacturing is also known as the "sunrise industry forever." Objective: to analyze the economic output of pharmaceutical manufacturing industry in China. The index system of the influencing factors is constructed and the quantitative analysis of the index system is carried out. The main factors affecting the economic output level of the pharmaceutical manufacturing industry in China and the changes of the influencing factors in different periods are obtained. On this basis, the countermeasures and suggestions to improve the economic output level of pharmaceutical manufacturing industry in China are put forward. The research results can provide data support and reference for pharmaceutical management departments and enterprises to make management decisions. At the same time, it can also provide reference for researchers in related fields. Methods: qualitative and quantitative methods were used in this study. The market demand and economic output of pharmaceutical manufacturing industry in China are analyzed in terms of absolute number, composition ratio, annual growth rate and so on. And through the construction of grey GM (1 ~ 1) forecasting model, the trend of the future pharmaceutical manufacturing capacity in China is forecasted. On the basis of literature analysis, there are 11 factors in five aspects: input of basic elements, factors of pharmaceutical science and technology, factors of market demand, factors of degree of opening to the outside world, and environmental factors of industrial development. To construct the index system of factors influencing the output of pharmaceutical manufacturing industry in China. According to the index data of the medical statistics yearbook of our country, grey correlation method is used to quantify the influencing factors, and the order and change of the influencing factors are obtained. Results: the results show that there are still many problems in the development of pharmaceutical manufacturing industry in China, such as the small scale of pharmaceutical manufacturing enterprises, low concentration, unbalanced development of regional pharmaceutical manufacturing industry, unremarkable regional characteristics, etc. At the same time, through the analysis of the influencing factors, it is found that the output level of pharmaceutical manufacturing industry in China depends on the investment of capital and labor to a large extent in a certain period of time, and in recent years, the role of scientific and technological factors in the process of industrial development has been improved. The influence of the degree of opening to the outside world is weakened, and the factors of industrial development environment and market demand have a stable effect on the economic output of pharmaceutical manufacturing industry in a certain period of time. Conclusion: this study is based on the authoritative data of the National Bureau of Statistics, the National Health and Family Planning Commission, the Ministry of Industry and Information Technology, and the China Chamber of Commerce for the Import and Export of Health products. The analytical data are true and reliable. In the process of analysis, taking the data of the influencing factors of 28 provinces in 2006 and 2010 as samples, combining the sample size and the distribution characteristics of the data, it is more appropriate to select the grey relational analysis method to analyze. On the basis of comprehensive analysis, suggestions and countermeasures for improvement are further discussed in order to improve the economic output level of Chinese pharmaceutical manufacturing industry and promote the development of pharmaceutical manufacturing industry.
【学位授予单位】:北京中医药大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:F426.72
【参考文献】
相关期刊论文 前10条
1 陆静超;经济增长理论的沿革与创新——评新古典增长理论与新增长理论[J];哈尔滨工业大学学报(社会科学版);2004年05期
2 张世龙;刘琳琳;任佳希;;我国区域医药制造业竞争力评价与分析——基于大陆省经济区域数据的实证研究[J];杭州电子科技大学学报(社会科学版);2011年01期
3 解晓燕;缪建营;;国际原油价格主控因素的实证研究——基于2006-2011年的时间序列数据分析[J];价格理论与实践;2011年12期
4 岳纯;赵洪进;;FDI和产业规模与我国医药产业市场集中度关系的研究[J];商业经济;2009年24期
5 熊广勤;;FDI、进出口贸易与产业集群对中部地区经济增长影响的实证研究[J];商业经济;2010年23期
6 海闻;国际贸易理论的新发展[J];经济研究;1995年07期
7 王新,朱文新;中国医药工业影响因素的组合作用分析[J];吉林工业大学自然科学学报;1999年01期
8 梁莱歆;张焕凤;袁艺;;基于DEA的企业R&D有效性研究[J];科研管理;2006年06期
9 江静;;中国省际R&D强度差异的决定与比较——基于1998-2004年的实证分析[J];南京大学学报(哲学.人文科学.社会科学版);2006年03期
10 邓力群;;我国R&D投入对TFP贡献的实证分析[J];南京社会科学;2011年04期
,本文编号:2356761
本文链接:https://www.wllwen.com/jingjilunwen/gongyejingjilunwen/2356761.html